3 Big Medtech Takeaways From US Midterms
Executive Summary
The balance of power will be shifting in Washington, DC, following the Nov. 6 US midterm elections, but that probably will not mean major changes for medtech policies. Here are some key takeaways from the election for device and diagnostics companies.
You may also be interested in...
Newly Elected Dems Will Defend Preexisting Conditions, May Fight Device Tax Repeal
Experts predicted continuing fights over insurance protections for preexisting conditions, and that newly elected Democrats may oppose device tax repeal in 2019 and 2020, due to the potential loss of federal revenue to pay for expanded health care coverage.
US Midterms: Industry Loses Some Supporters In Congress, But Retains Many
With most of the Nov. 6 election tally completed, it’s clear there will be many new faces for the device industry to engage with in the halls of Congress, but the sector still appears to have a significant group of supporters on Capitol Hill. Also, several medtech-relevant measures were on the ballot.
US Midterms: Industry Loses Some Supporters In Congress, But Retains Many
With most of the Nov. 6 election tally completed, it’s clear there will be many new faces for the device industry to engage with in the halls of Congress, but the sector still appears to have a significant group of supporters on Capitol Hill. Also, several medtech-relevant measures were on the ballot.